Inventor
BLAGG JULIAN
GB31 patents
⚠️ This page may combine multiple inventors who share the name “BLAGG JULIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
10 patentsUS6180627B1Jan 30, 2001
Antithrombotic agents
PFIZER55 citations89
US6579982B1Jun 17, 2003
Pyrimidine-2,4,6-trione metalloproteinase inhibitors
PFIZER10 citations74
US6936619B2Aug 30, 2005
Quinazolinone compounds useful in therapy
PFIZER7 citations70
US5767139AJun 16, 1998
Indoles which have steroid 5-α reductase inhibitory activity
PFIZER13 citations68
US6949577B2Sep 27, 2005
Pharmaceuticals
PFIZER6 citations62
US5912357AJun 15, 1999
Indole derivatives as 5-α-reductase-1-inhibitors
PFIZER5 citations62
US5696146ADec 9, 1997
Indole derivatives as steroid 5α-reductase inhibitors
PFIZER2 citations62
US6417203B1Jul 9, 2002
Antithrombotic agents
PFIZER5 citations59
US5922747AJul 13, 1999
Indole derivatives as steroid 5α-reductase inhibitors
PFIZER0 citations52
US7928099B2Apr 19, 2011
Pyrimido [4,5-D] azepine derivatives as 5-HT2c agonists
PFIZER1 citations45
CANCER RESEARCH TECH LTD
10 patentsUS9902721B2Feb 27, 2018
N2-phenyl-pyrido[3,4-d]pyrimidine-2, 8-diamine derivatives and their use as Mps1 inhibitors
CANCER RESEARCH TECH LTD7 citations83
US10479788B2Nov 19, 2019
Compounds that inhibit MPS1 kinase
CANCER RESEARCH TECH LTD4 citations82
US9890157B2Feb 13, 2018
Inhibitor compounds
CANCER RESEARCH TECH LTD10 citations82
US9834552B2Dec 5, 2017
Inhibitor compounds
CANCER RESEARCH TECH LTD8 citations82
US10399974B2Sep 3, 2019
N2-phenyl-pyrido[3,4-D]pyrimidine-2, 8-diamine derivatives and their use as Mps1 inhibitors
CANCER RESEARCH TECH LTD3 citations72
US11897877B2Feb 13, 2024
Inhibitor compounds
CANCER RESEARCH TECH LTD2 citations71
US11046688B2Jun 29, 2021
Inhibitor compounds
CANCER RESEARCH TECH LTD2 citations71
US10501462B2Dec 10, 2019
Pyrrolo[3,2-c]pyridine-6-amino derivatives
CANCER RESEARCH TECH LTD3 citations70
US9895364B2Feb 20, 2018
Pharmacologically active compounds
CANCER RESEARCH TECH LTD1 citations51
US10188642B2Jan 29, 2019
Pharmacologically active compounds
CANCER RESEARCH TECH LTD0 citations50